The Shandra Eisenga TB Study Act of 2026 mandates a federal study to evaluate the feasibility of developing a standardized tuberculosis test for human donor tissue to improve transplant safety.
John Moolenaar
Representative
MI-2
The Shandra Eisenga TB Study Act of 2026 mandates a comprehensive study to determine the feasibility of developing a standardized tuberculosis test for human donor tissue. By collaborating with federal health agencies and industry experts, this initiative aims to enhance transplant safety and improve the integrity of organ and tissue donation systems. The findings and recommendations from this study will be reported to Congress to guide future regulatory and implementation efforts.
Shandra Eisenga TB Study Act Proposes New Safety Standards for Organ and Tissue Transplants by 2026
The Shandra Eisenga TB Study Act of 2026 sets a two-year deadline for the Department of Health and Human Services (HHS) to figure out if we can create a reliable, standardized test to catch tuberculosis (TB) in tissue from deceased donors. Right now, when someone passes away and their tissues or organs are donated, the screening process for TB isn't always uniform. This bill aims to close that gap by tasking the heavy hitters at the NIH, CDC, and FDA to team up with organ procurement organizations and tissue banks to develop a foolproof detection method. Under Section 2, the goal is simple: make sure the gift of life doesn't accidentally come with a life-threatening infection.
Closing the Screening Gap
This isn't just a theoretical exercise for scientists; it’s about the nuts and bolts of how we handle donations. The study will look into the practical stuff—like how to collect samples from a deceased donor, how fast the results need to come back to be useful, and how to keep the lab workers safe while they're testing. Think of it like a quality control upgrade for a supply chain where the 'products' are heart valves, skin grafts, and corneas. By assessing existing research gaps and evaluating current testing methods, the government wants to move toward a system where every piece of donated tissue meets the same high safety standard, regardless of which hospital or tissue bank it passes through.
From Lab Bench to Hospital Bed
The bill specifically asks for pilot studies that include diverse and high-risk populations to ensure the test works for everyone. This means the Secretary will be looking at data from a wide range of sites, including medical examiners' offices and community hospitals. For a patient waiting on a transplant, this study is the first step toward a future where they can have more peace of mind. By the three-year mark, the Secretary has to hand over a report to Congress with a clear 'yes' or 'no' on whether this test is feasible and what laws might need to change to make it a reality. They are authorized to use existing department funds through 2031 to get this done, meaning they can start digging into the data without waiting for a brand-new budget line.